Magneleaf With Cbd

Menthol, Arnica Montana, Methyl Salicylate

M J Green Enterprises, Inc.
Human Otc Drug
NDC 82900-111

Magneleaf With Cbd also known as Menthol, Arnica Montana, Methyl Salicylate is a human otc drug labeled by 'M J Green Enterprises, Inc.'. National Drug Code (NDC) number for Magneleaf With Cbd is 82900-111. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Magneleaf With Cbd drug includes Arnica Montana - 8.5 g/170.96g Menthol - 17 g/170.96g Methyl Salicylate - 1 g/170.96g . The currest status of Magneleaf With Cbd drug is Active.

Drug Information:

Drug NDC:	82900-111
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Magneleaf With Cbd
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Menthol, Arnica Montana, Methyl Salicylate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	M J Green Enterprises, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ARNICA MONTANA - 8.5 g/170.96g MENTHOL - 17 g/170.96g METHYL SALICYLATE - 1 g/170.96g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	22 Nov, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	M J Green Enterprises, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0082900111130
UPC stands for Universal Product Code.
UNII:	O80TY208ZW L7T10EIP3A LAV5U5022Y
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
82900-111-13	170.96 g in 1 CAN (82900-111-13)	22 Nov, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Magneleaf With Cbd

Menthol, Arnica Montana, Methyl Salicylate

Cream
M J Green Enterprises, Inc.
NDC: 82900-111

Magneleaf Cbd Thc

Menthol, Arnica Montana, Methyl Salicylate

Cream
M J Green Enterprises, INC.
NDC: 82900-112

Purpose:

Purpose topical analgesic

Product Elements:

Magneleaf with cbd menthol, arnica montana, methyl salicylate menthol menthol peg-8 beeswax jojoba oil cannabidiol magnesium chloride coconut oil arnica montana arnica montana methyl salicylate salicylic acid shea butter water alpha-tocopherol maranta arundinacea root cream

Indications and Usage:

Uses temporary relief of aches and pains associated with: arthritis, carpal tunnel, swelling, sprains, bruising, inflammation

Warnings:

Warnings for external use only.

When Using:

When using this product: avoid contact with eyes, avoid use on deep wounds, avoid if you are allergic to listed ingredients. stop use and consult a doctor if: condition worsens, symptoms last for more than 7 days, condition clears up but occurs again in a few days, rash or irritation occurs.

Dosage and Administration:

Dosage apply to affected area 1 to 4 times daily, or as needed. keep out of reach of children keep out of reach of children

Stop Use:

Stop use and consult a doctor if: condition worsens, symptoms last for more than 7 days, condition clears up but occurs again in a few days, rash or irritation occurs.

Package Label Principal Display Panel:

6 ounce jar label - 6 oz jar magneleaf pain relief 3000 label

6 ounce lid label magneleaf 3000 6 oz jar lid label

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.